Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review Read More > October 17, 2013
Self-Medication of LSD and MDMA to Treat Mental Disorders: A Case Series Read More > September 18, 2013
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors Read More > December 19, 2012
Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study Read More > November 20, 2012
A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Read More > October 31, 2012
The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions Read More > July 27, 2012
